CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Cash flows from operating activities:
Net loss	$ (35,561)	$ (12,025)
Adjustments to reconcile net loss to cash used in operating activities:
Depreciation	205	84
Stock-based compensation expense	2,043	517
Change in fair value of preferred stock warrant liability	(58)	193
Changes in operating assets and liabilities:
Other receivables	26	(366)
Prepaids and other current and non-current assets	(926)	(1,690)
Accounts payable	1,434	1,099
Accrued expenses and other non-current liabilities	7,926	3,223
Net cash used in operating activities	(24,911)	(8,965)
Cash flows from investing activities:
Purchases of property and equipment	(2,223)	(320)
Net cash used in investing activities	(2,223)	(320)
Cash flows from financing activities:
Issuance of common stock upon initial public offering, net of underwriters' fees	114,267
Payment of offering costs	(1,277)	(173)
Proceeds from the exercise of Series A-2 warrants	406
Proceeds from issuance of Series A-2 convertible preferred stock, net of issuance costs		15,988
Issuance costs of Series B convertible preferred stock		(2)
Net cash provided by financing activities	113,396	15,813
Effect of exchange rate changes on cash	(340)	20
Net increase in cash, cash equivalents and restricted cash	85,922	6,548
Cash, cash equivalents and restricted cash at beginning of period	134,368	9,778
Cash, cash equivalents and restricted cash at end of period	220,290	16,326
Components of cash, cash equivalents and restricted cash
Cash and cash equivalents	218,817	16,326
Restricted Cash	1,473
Total cash, cash equivalents and restricted cash at end of period	220,290	16,326
Supplemental noncash investing and financing activities
Property and equipment included in accounts payable and accrued expenses	244
Deferred offering costs in accounts payable and accrued expenses	$ 1,420	40
Series A-2 Convertible Preferred stock issuance costs included in accrued expenses		8
Series B convertible preferred stock issuance costs included in accrued expenses		$ 27